WCN24-750 ASSESSMENT OF DRUG INTERACTIONS WITH IPTACOPAN
Saved in:
| Main Authors: | Robert Schmouder, Kenneth Kulmatycki, Bharti Shah, Amanda Taylor, Prasanna Kumar Nidamarthy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924003206 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN24-555 PHARMACOKINETICS OF SINGLE DOSES OF IPTACOPAN
by: Robert Schmouder, et al.
Published: (2024-04-01) -
WCN24-550 SINGLE DOSE OF IPTACOPAN TREATMENT RAPIDLY DESCREASES PLASMA COMPLEMENT Bb LEVELS
by: Robert Schmouder, et al.
Published: (2024-04-01) -
WCN24-748 ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS
by: Robert Schmouder, et al.
Published: (2024-04-01) -
WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE eGFR 20-<30 mL/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS
by: Dmitrij Kollins, et al.
Published: (2025-02-01) -
WCN24-1146 SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
by: Nicholas Webb, et al.
Published: (2024-04-01)